• What we do

    What we do +

    We support clinical and pre-clinical studies and provide earlier, convincing evidence for a therapeutic effect in inflammatory arthritis and inflammatory cancers by utilizing advanced imaging, computer-aided scoring routines and patented methodologies.

    Publications

    Publications +

    Studies on early efficacy imaging markers for rheumatoid, psoriatic and osteoarthritis and ankylosis spondylitis patients imaged with MRI, DCE-MRI, Ultrasound, X-rays as well as computer-aided quantification of perfusion and morphology of tumors in inflammatory cancers.

    Testimonials

    Testimonials +

    Improving study economics, standardizing imaging and automating scoring routines for customers in pharmaceutical and biotech companies. Testimonials from our customers on use of Dynamika and Image Analysis team in their MRI clinical trials and studies

    Team

    Team +

    Innovation driven, agile and dedicated team, working in partnership with leading academics and clinical specialists and delivering the best medical imaging solutions and expert advice to ensure success of your clinical study.

  • Trial Support Service

    Trial Support Service +

    We deliver accurate and comprehensive image analytics and provide full support of early phase trials and R&D studies crucial to make go / no-go decision on further development of the compound.

    Therapeutic Areas

    Therapeutic Areas +

    We deliver the most comprehensive set of imaging markers and ensure that Sponsors and Investigators are fully informed of the treatment profile when making a decision on the success of the compound.

    Clinical Trial Team

    Clinical Trial Team +

    Dedicated team of clinical and radiology experts, software engineers and algorithm developers will be engaged to deliver bespoke end-to-end support for your imaging study.

    MRI as Early Biomarker

    MRI as Early Biomarker +

    Expert opinions and video lectures on the latest technologies for visualisation, analysis, and reporting of DCE-MRI and MRI images acquired in clinical or pre-clinical studies.

  • Cloud-based Logistics

    Cloud-based Logistics +

    Dynamika is used by bio- pharmaceutical companies and academic investigators to improve image logistics, automate image quality assurance, and standardize advanced imaging data analysis.

    Your Study Initiation

    Your Study Initiation +

    Deliverign yoru study on budget and on time with the cloud based infrastructure, patented scoring methodologies, innovate imaging, and network of experts.

    Case Studies

    Case Studies +

    Case studies and clinical routine examples of using advanced imaging and quantitative image markers for highly efficient interpretation and management of imaging data

    Dynamika for FREE

    Dynamika for FREE +

    Dynamika is the best link between cutting academic research and clinical trial word. We ensure that you benefit from the latest science delivered within standardized regulated environment

  • Connect



    DYNAMIKA USERS:
    E: dynamika @ imageanalysis.org.uk
    T: + 44 20 7630 9926

    PROJECT SUPPORT:
    E: support @ imageanalysis.org.uk
    T: +44 (0) 78 12 001 187



    Discuss your Study (Europe)

    IMAGE ANALYSIS, LTD
    QABC Minster House
    272-274 Vauxhall Bridge Road
    London, SW1V 1BA
    United Kingdom

    T: + 44 (0) 207 630 9926
    E: contact @ imageanalysis.org.uk

    Discuss your Study (United States)

    IMAGE ANALYSIS, INC
    10 Trotters Way
    Jackson, New Jersey
    08527
    USA

    T: + 1 215 796-8100
    E: contact @ imageanalysis.org.uk

Company News

Precision Medicine in Today’s Healthcare, Professor Richard Barker, Chairman of Image Analysis speaks at BioTrinity 2016, 25 – 27 April 2016

Professor Richard Barker, OBE, Chairman of Image Analysis will speak at the BioTrinity 2016 – Europe’s Leading Investment and Biopartnering Conference, 25 – 27 April 2016 on Precision Medicine in Today’s Healthcare. http://www.biotrinity.com/ Find out more how Image Analysis is changing today’s clinical research by sending an email to contact@imageanalysis.org.uk

Machine Learning: Transforming Oncology Clinical Trials, Dr. Olga Kubassova, CEO of Image Analysis speaks at Royal Society of Medicine, 15/04/2016

Dr. Olga Kubassova, CEO of Image Analysis will speak at the Royal Society of Medicine on how the machine learning and cloud based technologies transform Oncology Clinical Trials. Join her on the 15th April 2016 or request a meeting by sending meeting request to contact@imageanalysis.org.uk Standardised acquisition and comprehensive automated analysis of medical images are [...]

Tumour response assessment on multi-parametric MRI after stereotactic ablative body radiotherapy for primary kidney cancer

Novel work in ‘Tumour response assessment on multi-parametric MRI after stereotactic  ablative body radiotherapy for primary kidney cancer’ was accepted as an oral presentation at ICCR 27-30 June, London. Introduction: Stereotactic ablative body radiotherapy (SABR) is a novel high-precision treatment modality for patients with primary renal cell carcinoma (RCC) [1]. Recently, our group completed a Phase Ib [...]

View all news

Blog

Danger of ‘Gadolinium Phobia’

By Philip Ward, AuntMinnie.com staff writer March 4, 2016 Post European Congress of Radiology (ECR) and publication of several articles in European newspapers, AuntMinnie, the leading radiology news website reports that ‘there’s a serious risk of a phobia developing over the use of gadolinium-based MRI contrast agents’. At ECR, Dr. Alexander Radbruch, a radiologist at Heidelberg University [...]

Synovitis in knee osteoarthritis: a precursor of disease?

Synovitis in knee osteoarthritis: a precursor of disease? - another evidence paper confirming the importance of measuring early inflammatory changes occurring prior to degenerative damage in patients with osteoarthritis (OA) is now available on:http://ard.bmj.com/content/early/2014/12/08/annrheumdis-2014-205894.abstract This late 2014 paper has been followed on by a number of research papers confirming the need for earlier biomarkers in OA [...]

Disruptive Innovations Cure HealthCare

We would like to share some insights from a fascinating post on how innovation can disrupt the normal routine of healthcare, written by Clayton M. Christensen, Richard Bohmer, and John Kenagy, Harvard Business School, and a clinical associate professor of surgery at the University of Washington in Seattle. Imagine a portable, low-intensity X-ray machine that can be wheeled between offices on a small cart. [...]

View more posts

Latest Tweets

RT @vRad: Report says CAD will dominate #imaging market for next 5 years due to #mammography & #MRI applications http://t.co/Divka2CZWx

RT @BioMedCentral: RT @stefaniealaimo: #MRI detects early effects of #chemotherapy on children’s hearts from @BioMedCentral blog http://t.c…

RT @OlgaKubassova: #Mammography has not reduced deaths from #breast cancer. Real need for effective #imaging for early detection - #MRI htt…

RT @OlgaKubassova: Early Treatment Start Key to RA Remission http://t.co/3AhJWLvqOB

Market growth & overview of #imageanalysis #software market driven by demand for diagnostic procedures & #technology http://t.co/wHoi0He0cL

@sarahhowardview @downingstreet brilliantly :) great event for #smallbusiness and #innovation driven enterprisers http://t.co/wJWvy5bmOe

RT @jemilad: Great talk by @OlgaKubassova on how @ImageAnalysisUK delivers objectivity, efficiency and precision in medical image analysis …